第一单位：
Chest Disease Department, University Hospital, 3 Boulevard Fleming, 25030, Besançon, France. geberst@chu-besancon.fr.;Methodology and Quality of Life in Oncology Unit, University Hospital, Besançon, France. geberst@chu-besancon.fr.;Université de Bourgogne Franche-Comté, EFS BFC, INSERM, UMR1098, RIGHT, Besançon, France. geberst@chu-besancon.fr.
作者：
Guillaume,Eberst [1]
;
Dewi,Vernerey [2]
;
Caroline,Laheurte [3]
;
Aurélia,Meurisse [4]
;
Vincent,Kaulek [5]
;
Laurie,Cuche [5]
;
Pascale,Jacoulet [5]
;
Hamadi,Almotlak [6]
;
Jean,Lahourcade [5]
;
Marie,Gainet-Brun [5]
;
Elizabeth,Fabre [7]
;
Françoise,Le Pimpec-Barthes [8]
;
Olivier,Adotevi [9]
;
Virginie,Westeel [10]
作者单位：
Chest Disease Department, University Hospital, 3 Boulevard Fleming, 25030, Besançon, France. geberst@chu-besancon.fr.;Methodology and Quality of Life in Oncology Unit, University Hospital, Besançon, France. geberst@chu-besancon.fr.;Université de Bourgogne Franche-Comté, EFS BFC, INSERM, UMR1098, RIGHT, Besançon, France. geberst@chu-besancon.fr.
[1]
Methodology and Quality of Life in Oncology Unit, University Hospital, Besançon, France.;Université de Bourgogne Franche-Comté, EFS BFC, INSERM, UMR1098, RIGHT, Besançon, France.
[2]
Université de Bourgogne Franche-Comté, EFS BFC, INSERM, UMR1098, RIGHT, Besançon, France.;INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Biomonitoring Platform, F-25000, Besançon, France.
[3]
Methodology and Quality of Life in Oncology Unit, University Hospital, Besançon, France.
[4]
Chest Disease Department, University Hospital, 3 Boulevard Fleming, 25030, Besançon, France.
[5]
Department of Medical Oncology, University Hospital, Besançon, France.
[6]
Department of Medical Oncology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
[7]
Department of Thoracic surgery, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
[8]
Université de Bourgogne Franche-Comté, EFS BFC, INSERM, UMR1098, RIGHT, Besançon, France.;INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Biomonitoring Platform, F-25000, Besançon, France.;Department of Medical Oncology, University Hospital, Besançon, France.
[9]
Chest Disease Department, University Hospital, 3 Boulevard Fleming, 25030, Besançon, France.;Methodology and Quality of Life in Oncology Unit, University Hospital, Besançon, France.;Université de Bourgogne Franche-Comté, EFS BFC, INSERM, UMR1098, RIGHT, Besançon, France.
[10]
DOI
10.1186/s12885-022-09628-8
PMID
35546670
发布时间
2022-07-16
换一批
